Stock Events

Sinopharm Group 

€11.3
44
+€0+0% Thursday 08:41

Statistics

Day High
11.5
Day Low
11.3
52W High
-
52W Low
-
Volume
200
Avg. Volume
-
Mkt Cap
7.36B
P/E Ratio
6.48
Dividend Yield
5.05%
Dividend
0.57

Upcoming

Dividends

5.05%Dividend Yield
10Y Growth
13.69%
5Y Growth
8.54%
3Y Growth
8.65%
1Y Growth
8.68%

Earnings

25AugExpected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.69
1.04
1.4
1.75
Expected EPS
1.4800067469359999
Actual EPS
1.2762377020679998

People Also Follow

This list is based on the watchlists of people on Stock Events who follow X2S1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
CEO
Mr. Wanyong Lian
Employees
113635
Country
US
ISIN
US82937K1016
WKN
000A2P3LX

Listings